Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Immuno-Oncology Revenue

1.5 Market Analysis by Type

1.5.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Immune Checkpoint Inhibitors

1.5.3 Monoclonal Antibodies

1.5.4 Cytokine-Based Immunotherapy

1.5.5 Cancer Vaccines

1.5.6 CAR-T Cell Therapy

1.6 Market by Application

1.6.1 Global Immuno-Oncology Market Share by Application: 2022-2027

1.6.2 Hospitals

1.6.3 Pharmacies

1.6.4 Online Pharmacies

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Immuno-Oncology Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Immuno-Oncology Market Players Profiles

3.1 Amgen, Inc

3.1.1 Amgen, Inc Company Profile

3.1.2 Amgen, Inc Immuno-Oncology Product Specification

3.1.3 Amgen, Inc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 AstraZeneca, Plc

3.2.1 AstraZeneca, Plc Company Profile

3.2.2 AstraZeneca, Plc Immuno-Oncology Product Specification

3.2.3 AstraZeneca, Plc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Bristol-Myers Squibb

3.3.1 Bristol-Myers Squibb Company Profile

3.3.2 Bristol-Myers Squibb Immuno-Oncology Product Specification

3.3.3 Bristol-Myers Squibb Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Celgene Corporation

3.4.1 Celgene Corporation Company Profile

3.4.2 Celgene Corporation Immuno-Oncology Product Specification

3.4.3 Celgene Corporation Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Eli Lilly and Company

3.5.1 Eli Lilly and Company Company Profile

3.5.2 Eli Lilly and Company Immuno-Oncology Product Specification

3.5.3 Eli Lilly and Company Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Merck & Co.

3.6.1 Merck & Co. Company Profile

3.6.2 Merck & Co. Immuno-Oncology Product Specification

3.6.3 Merck & Co. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Hoffmann-La Roche AG

3.7.1 Hoffmann-La Roche AG Company Profile

3.7.2 Hoffmann-La Roche AG Immuno-Oncology Product Specification

3.7.3 Hoffmann-La Roche AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Johnson & Johnson

3.8.1 Johnson & Johnson Company Profile

3.8.2 Johnson & Johnson Immuno-Oncology Product Specification

3.8.3 Johnson & Johnson Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Novartis International AG

3.9.1 Novartis International AG Company Profile

3.9.2 Novartis International AG Immuno-Oncology Product Specification

3.9.3 Novartis International AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 AbbVie

3.10.1 AbbVie Company Profile

3.10.2 AbbVie Immuno-Oncology Product Specification

3.10.3 AbbVie Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Pfizer Inc.

3.11.1 Pfizer Inc. Company Profile

3.11.2 Pfizer Inc. Immuno-Oncology Product Specification

3.11.3 Pfizer Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Sanofi S.A.

3.12.1 Sanofi S.A. Company Profile

3.12.2 Sanofi S.A. Immuno-Oncology Product Specification

3.12.3 Sanofi S.A. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 EMD Serono

3.13.1 EMD Serono Company Profile

3.13.2 EMD Serono Immuno-Oncology Product Specification

3.13.3 EMD Serono Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Gilead Sciences Inc.

3.14.1 Gilead Sciences Inc. Company Profile

3.14.2 Gilead Sciences Inc. Immuno-Oncology Product Specification

3.14.3 Gilead Sciences Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 Prometheus Therapeutics & Diagnostics

3.15.1 Prometheus Therapeutics & Diagnostics Company Profile

3.15.2 Prometheus Therapeutics & Diagnostics Immuno-Oncology Product Specification

3.15.3 Prometheus Therapeutics & Diagnostics Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.16 Aduro BioTech

3.16.1 Aduro BioTech Company Profile

3.16.2 Aduro BioTech Immuno-Oncology Product Specification

3.16.3 Aduro BioTech Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.17 Galena Biopharma

3.17.1 Galena Biopharma Company Profile

3.17.2 Galena Biopharma Immuno-Oncology Product Specification

3.17.3 Galena Biopharma Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.18 Bavarian Nordic

3.18.1 Bavarian Nordic Company Profile

3.18.2 Bavarian Nordic Immuno-Oncology Product Specification

3.18.3 Bavarian Nordic Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.19 Celldex Therapeutics

3.19.1 Celldex Therapeutics Company Profile

3.19.2 Celldex Therapeutics Immuno-Oncology Product Specification

3.19.3 Celldex Therapeutics Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.20 ImmunoCellular Therapeutics

3.20.1 ImmunoCellular Therapeutics Company Profile

3.20.2 ImmunoCellular Therapeutics Immuno-Oncology Product Specification

3.20.3 ImmunoCellular Therapeutics Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.21 Incyte

3.21.1 Incyte Company Profile

3.21.2 Incyte Immuno-Oncology Product Specification

3.21.3 Incyte Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Immuno-Oncology Market Competition by Market Players

4.1 Global Immuno-Oncology Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Immuno-Oncology Revenue Market Share by Market Players (2016-2021)

4.3 Global Immuno-Oncology Average Price by Market Players (2016-2021)

5 Global Immuno-Oncology Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Immuno-Oncology Market Size (2016-2021)

5.1.2 Immuno-Oncology Key Players in North America (2016-2021)

5.1.3 North America Immuno-Oncology Market Size by Type (2016-2021)

5.1.4 North America Immuno-Oncology Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Immuno-Oncology Market Size (2016-2021)

5.2.2 Immuno-Oncology Key Players in East Asia (2016-2021)

5.2.3 East Asia Immuno-Oncology Market Size by Type (2016-2021)

5.2.4 East Asia Immuno-Oncology Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Immuno-Oncology Market Size (2016-2021)

5.3.2 Immuno-Oncology Key Players in Europe (2016-2021)

5.3.3 Europe Immuno-Oncology Market Size by Type (2016-2021)

5.3.4 Europe Immuno-Oncology Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Immuno-Oncology Market Size (2016-2021)

5.4.2 Immuno-Oncology Key Players in South Asia (2016-2021)

5.4.3 South Asia Immuno-Oncology Market Size by Type (2016-2021)

5.4.4 South Asia Immuno-Oncology Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Immuno-Oncology Market Size (2016-2021)

5.5.2 Immuno-Oncology Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Immuno-Oncology Market Size by Type (2016-2021)

5.5.4 Southeast Asia Immuno-Oncology Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Immuno-Oncology Market Size (2016-2021)

5.6.2 Immuno-Oncology Key Players in Middle East (2016-2021)

5.6.3 Middle East Immuno-Oncology Market Size by Type (2016-2021)

5.6.4 Middle East Immuno-Oncology Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Immuno-Oncology Market Size (2016-2021)

5.7.2 Immuno-Oncology Key Players in Africa (2016-2021)

5.7.3 Africa Immuno-Oncology Market Size by Type (2016-2021)

5.7.4 Africa Immuno-Oncology Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Immuno-Oncology Market Size (2016-2021)

5.8.2 Immuno-Oncology Key Players in Oceania (2016-2021)

5.8.3 Oceania Immuno-Oncology Market Size by Type (2016-2021)

5.8.4 Oceania Immuno-Oncology Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Immuno-Oncology Market Size (2016-2021)

5.9.2 Immuno-Oncology Key Players in South America (2016-2021)

5.9.3 South America Immuno-Oncology Market Size by Type (2016-2021)

5.9.4 South America Immuno-Oncology Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Immuno-Oncology Market Size (2016-2021)

5.10.2 Immuno-Oncology Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Immuno-Oncology Market Size by Type (2016-2021)

5.10.4 Rest of the World Immuno-Oncology Market Size by Application (2016-2021)

6 Global Immuno-Oncology Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Immuno-Oncology Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Immuno-Oncology Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Immuno-Oncology Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Immuno-Oncology Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Immuno-Oncology Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Immuno-Oncology Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Immuno-Oncology Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Immuno-Oncology Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Immuno-Oncology Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Immuno-Oncology Consumption by Countries

7 Global Immuno-Oncology Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Immuno-Oncology (2022-2027)

7.2 Global Forecasted Revenue of Immuno-Oncology (2022-2027)

7.3 Global Forecasted Price of Immuno-Oncology (2022-2027)

7.4 Global Forecasted Production of Immuno-Oncology by Region (2022-2027)

7.4.1 North America Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.3 Europe Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.7 Africa Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.9 South America Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Immuno-Oncology Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Immuno-Oncology by Application (2022-2027)

8 Global Immuno-Oncology Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Immuno-Oncology by Country

8.2 East Asia Market Forecasted Consumption of Immuno-Oncology by Country

8.3 Europe Market Forecasted Consumption of Immuno-Oncology by Countriy

8.4 South Asia Forecasted Consumption of Immuno-Oncology by Country

8.5 Southeast Asia Forecasted Consumption of Immuno-Oncology by Country

8.6 Middle East Forecasted Consumption of Immuno-Oncology by Country

8.7 Africa Forecasted Consumption of Immuno-Oncology by Country

8.8 Oceania Forecasted Consumption of Immuno-Oncology by Country

8.9 South America Forecasted Consumption of Immuno-Oncology by Country

8.10 Rest of the world Forecasted Consumption of Immuno-Oncology by Country

9 Global Immuno-Oncology Sales by Type (2016-2027)

9.1 Global Immuno-Oncology Historic Market Size by Type (2016-2021)

9.2 Global Immuno-Oncology Forecasted Market Size by Type (2022-2027)

10 Global Immuno-Oncology Consumption by Application (2016-2027)

10.1 Global Immuno-Oncology Historic Market Size by Application (2016-2021)

10.2 Global Immuno-Oncology Forecasted Market Size by Application (2022-2027)

11 Global Immuno-Oncology Manufacturing Cost Analysis

11.1 Immuno-Oncology Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Immuno-Oncology

12 Global Immuno-Oncology Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Immuno-Oncology Distributors List

12.3 Immuno-Oncology Customers

12.4 Immuno-Oncology Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Immuno-Oncology Revenue (US$ Million) 2016-2021

Table 6. Global Immuno-Oncology Market Size by Type (US$ Million): 2022-2027

Table 7. Immune Checkpoint Inhibitors Features

Table 8. Monoclonal Antibodies Features

Table 9. Cytokine-Based Immunotherapy Features

Table 10. Cancer Vaccines Features

Table 11. CAR-T Cell Therapy Features

Table 16. Global Immuno-Oncology Market Size by Application (US$ Million): 2022-2027

Table 17. Hospitals Case Studies

Table 18. Pharmacies Case Studies

Table 19. Online Pharmacies Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Immuno-Oncology Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Immuno-Oncology Market Growth Strategy

Table 46. Immuno-Oncology SWOT Analysis

Table 47. Amgen, Inc Immuno-Oncology Product Specification

Table 48. Amgen, Inc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. AstraZeneca, Plc Immuno-Oncology Product Specification

Table 50. AstraZeneca, Plc Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Bristol-Myers Squibb Immuno-Oncology Product Specification

Table 52. Bristol-Myers Squibb Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Celgene Corporation Immuno-Oncology Product Specification

Table 54. Table Celgene Corporation Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Eli Lilly and Company Immuno-Oncology Product Specification

Table 56. Eli Lilly and Company Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Merck & Co. Immuno-Oncology Product Specification

Table 58. Merck & Co. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Hoffmann-La Roche AG Immuno-Oncology Product Specification

Table 60. Hoffmann-La Roche AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Johnson & Johnson Immuno-Oncology Product Specification

Table 62. Johnson & Johnson Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Novartis International AG Immuno-Oncology Product Specification

Table 64. Novartis International AG Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. AbbVie Immuno-Oncology Product Specification

Table 66. AbbVie Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. Pfizer Inc. Immuno-Oncology Product Specification

Table 68. Pfizer Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Sanofi S.A. Immuno-Oncology Product Specification

Table 70. Sanofi S.A. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. EMD Serono Immuno-Oncology Product Specification

Table 72. EMD Serono Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Gilead Sciences Inc. Immuno-Oncology Product Specification

Table 74. Gilead Sciences Inc. Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 75. Prometheus Therapeutics & Diagnostics Immuno-Oncology Product Specification

Table 76. Prometheus Therapeutics & Diagnostics Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 77. Aduro BioTech Immuno-Oncology Product Specification

Table 78. Aduro BioTech Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 79. Galena Biopharma Immuno-Oncology Product Specification

Table 80. Galena Biopharma Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 81. Bavarian Nordic Immuno-Oncology Product Specification

Table 82. Bavarian Nordic Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 83. Celldex Therapeutics Immuno-Oncology Product Specification

Table 84. Celldex Therapeutics Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 85. ImmunoCellular Therapeutics Immuno-Oncology Product Specification

Table 86. ImmunoCellular Therapeutics Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 87. Incyte Immuno-Oncology Product Specification

Table 88. Incyte Immuno-Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Immuno-Oncology Production Capacity by Market Players

Table 148. Global Immuno-Oncology Production by Market Players (2016-2021)

Table 149. Global Immuno-Oncology Production Market Share by Market Players (2016-2021)

Table 150. Global Immuno-Oncology Revenue by Market Players (2016-2021)

Table 151. Global Immuno-Oncology Revenue Share by Market Players (2016-2021)

Table 152. Global Market Immuno-Oncology Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Immuno-Oncology Market Share (2016-2021)

Table 155. North America Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Immuno-Oncology Market Share by Type (2016-2021)

Table 157. North America Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Immuno-Oncology Market Share by Application (2016-2021)

Table 159. East Asia Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Immuno-Oncology Market Share (2016-2021)

Table 162. East Asia Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Immuno-Oncology Market Share by Type (2016-2021)

Table 164. East Asia Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Immuno-Oncology Market Share by Application (2016-2021)

Table 166. Europe Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Immuno-Oncology Market Share (2016-2021)

Table 169. Europe Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Immuno-Oncology Market Share by Type (2016-2021)

Table 171. Europe Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Immuno-Oncology Market Share by Application (2016-2021)

Table 173. South Asia Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Immuno-Oncology Market Share (2016-2021)

Table 176. South Asia Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Immuno-Oncology Market Share by Type (2016-2021)

Table 178. South Asia Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Immuno-Oncology Market Share by Application (2016-2021)

Table 180. Southeast Asia Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Immuno-Oncology Market Share (2016-2021)

Table 183. Southeast Asia Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Immuno-Oncology Market Share by Type (2016-2021)

Table 185. Southeast Asia Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Immuno-Oncology Market Share by Application (2016-2021)

Table 187. Middle East Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Immuno-Oncology Market Share (2016-2021)

Table 190. Middle East Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Immuno-Oncology Market Share by Type (2016-2021)

Table 192. Middle East Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Immuno-Oncology Market Share by Application (2016-2021)

Table 194. Africa Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Immuno-Oncology Market Share (2016-2021)

Table 197. Africa Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Immuno-Oncology Market Share by Type (2016-2021)

Table 199. Africa Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Immuno-Oncology Market Share by Application (2016-2021)

Table 201. Oceania Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Immuno-Oncology Market Share (2016-2021)

Table 204. Oceania Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Immuno-Oncology Market Share by Type (2016-2021)

Table 206. Oceania Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Immuno-Oncology Market Share by Application (2016-2021)

Table 208. South America Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Immuno-Oncology Market Share (2016-2021)

Table 211. South America Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Immuno-Oncology Market Share by Type (2016-2021)

Table 213. South America Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Immuno-Oncology Market Share by Application (2016-2021)

Table 215. Rest of the World Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Immuno-Oncology Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Immuno-Oncology Market Share (2016-2021)

Table 218. Rest of the World Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Immuno-Oncology Market Share by Type (2016-2021)

Table 220. Rest of the World Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Immuno-Oncology Market Share by Application (2016-2021)

Table 222. North America Immuno-Oncology Consumption by Countries (2016-2021)

Table 223. East Asia Immuno-Oncology Consumption by Countries (2016-2021)

Table 224. Europe Immuno-Oncology Consumption by Region (2016-2021)

Table 225. South Asia Immuno-Oncology Consumption by Countries (2016-2021)

Table 226. Southeast Asia Immuno-Oncology Consumption by Countries (2016-2021)

Table 227. Middle East Immuno-Oncology Consumption by Countries (2016-2021)

Table 228. Africa Immuno-Oncology Consumption by Countries (2016-2021)

Table 229. Oceania Immuno-Oncology Consumption by Countries (2016-2021)

Table 230. South America Immuno-Oncology Consumption by Countries (2016-2021)

Table 231. Rest of the World Immuno-Oncology Consumption by Countries (2016-2021)

Table 232. Global Immuno-Oncology Production Forecast by Region (2022-2027)

Table 233. Global Immuno-Oncology Sales Volume Forecast by Type (2022-2027)

Table 234. Global Immuno-Oncology Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Immuno-Oncology Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Immuno-Oncology Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Immuno-Oncology Sales Price Forecast by Type (2022-2027)

Table 238. Global Immuno-Oncology Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Immuno-Oncology Consumption Value Forecast by Application (2022-2027)

Table 240. North America Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 241. East Asia Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 242. Europe Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 243. South Asia Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 245. Middle East Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 246. Africa Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 247. Oceania Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 248. South America Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Immuno-Oncology Consumption Forecast 2022-2027 by Country

Table 250. Global Immuno-Oncology Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Immuno-Oncology Revenue Market Share by Type (2016-2021)

Table 252. Global Immuno-Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Immuno-Oncology Revenue Market Share by Type (2022-2027)

Table 254. Global Immuno-Oncology Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Immuno-Oncology Revenue Market Share by Application (2016-2021)

Table 256. Global Immuno-Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Immuno-Oncology Revenue Market Share by Application (2022-2027)

Table 258. Immuno-Oncology Distributors List

Table 259. Immuno-Oncology Customers List





Figure 1. Product Figure

Figure 2. Global Immuno-Oncology Market Share by Type: 2021 VS 2027

Figure 3. Global Immuno-Oncology Market Share by Application: 2021 VS 2027

Figure 4. North America Immuno-Oncology Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 6. North America Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 7. United States Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 8. Canada Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 12. China Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 13. Japan Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 15. Europe Immuno-Oncology Consumption and Growth Rate

Figure 16. Europe Immuno-Oncology Consumption Market Share by Region in 2021

Figure 17. Germany Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 19. France Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 20. Italy Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 21. Russia Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 22. Spain Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 25. Poland Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Immuno-Oncology Consumption and Growth Rate

Figure 27. South Asia Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 28. India Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Immuno-Oncology Consumption and Growth Rate

Figure 30. Southeast Asia Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 31. Indonesia Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Immuno-Oncology Consumption and Growth Rate

Figure 37. Middle East Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 38. Turkey Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 40. Iran Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 42. Africa Immuno-Oncology Consumption and Growth Rate

Figure 43. Africa Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 44. Nigeria Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Immuno-Oncology Consumption and Growth Rate

Figure 47. Oceania Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 48. Australia Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 49. South America Immuno-Oncology Consumption and Growth Rate

Figure 50. South America Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 51. Brazil Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Immuno-Oncology Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Immuno-Oncology Consumption and Growth Rate

Figure 54. Rest of the World Immuno-Oncology Consumption Market Share by Countries in 2021

Figure 55. Global Immuno-Oncology Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Immuno-Oncology Price and Trend Forecast (2022-2027)

Figure 58. North America Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 59. North America Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 75. South America Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Immuno-Oncology Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Immuno-Oncology Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Immuno-Oncology Consumption Forecast 2022-2027

Figure 79. East Asia Immuno-Oncology Consumption Forecast 2022-2027

Figure 80. Europe Immuno-Oncology Consumption Forecast 2022-2027

Figure 81. South Asia Immuno-Oncology Consumption Forecast 2022-2027

Figure 82. Southeast Asia Immuno-Oncology Consumption Forecast 2022-2027

Figure 83. Middle East Immuno-Oncology Consumption Forecast 2022-2027

Figure 84. Africa Immuno-Oncology Consumption Forecast 2022-2027

Figure 85. Oceania Immuno-Oncology Consumption Forecast 2022-2027

Figure 86. South America Immuno-Oncology Consumption Forecast 2022-2027

Figure 87. Rest of the world Immuno-Oncology Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Immuno-Oncology

Figure 89. Manufacturing Process Analysis of Immuno-Oncology

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Immuno-Oncology Supply Chain Analysis